What We're Reading: Page 28
Industry reads hand-picked by our editors
Apr 18, 2025
Apr 17, 2025
-
The Washington Post
Internal budget document reveals extent of Trump’s proposed health cuts
-
The Wall Street Journal
Drug Development Is Slowing Down After Cuts at the FDA
-
The Boston Globe
Autism science at risk as RFK Jr. revives debunked theories
-
Nature
Japan’s big bet on stem-cell therapies might soon pay off with medical breakthroughs
Apr 16, 2025
Apr 15, 2025
Apr 14, 2025
-
The Washington Post
Millions in the U.S. take this drug. Tariffs could complicate their care.
-
The Wall Street Journal
The Chinese CEO Who Believes Her Cancer Drug Can Beat Merck’s Bestseller
-
AP News
Measles: How stagnant vaccine funding helped Texas outbreak spread
-
The Boston Globe
‘I think it is actively happening’: Is Boston’s biotech industry doomed?
Apr 11, 2025
-
Bloomberg
Trump Tariff Turmoil Won’t Faze GSK CEO Emma Walmsley
-
Endpoints News
Tome Bio founders wrangle ‘jumping genes’ for new gene insertion tool
-
AP News
FDA reverses course on telework after layoffs and resignations
-
Nature News
Biggest brain map ever details huge number of neurons and their activity
Apr 10, 2025
-
The Wall Street Journal
Market Volatility to Drive Closer Collaboration Between Biotech Startups, Large Pharma
-
Bloomberg
Blackstone Hires Former Pfizer Scientist to Find Blockbusters
-
Roll Call
As Kennedy tours West, frustrated Democrats demand meeting
-
Stat
The trade war hits pause, but the biotech doom loop carries on
Previous
